Arginine metabolism: a potential target in pancreatic cancer therapy
Arginine metabolism: a potential target in pancreatic cancer therapy
About this item
Full title
Author / Creator
Publisher
China: Lippincott Williams & Wilkins
Journal title
Language
English
Formats
Publication information
Publisher
China: Lippincott Williams & Wilkins
Subjects
More information
Scope and Contents
Contents
Pancreatic ductal adenocarcinoma (PDAC) is an extremely malignant disease, which has an extremely low survival rate of <9% in the United States. As a new hallmark of cancer, metabolism reprogramming exerts crucial impacts on PDAC development and progression. Notably, arginine metabolism is altered in PDAC cells and participates in vital signaling p...
Alternative Titles
Full title
Arginine metabolism: a potential target in pancreatic cancer therapy
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_4956a5e07cb34a7297ce748e9f40e899
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_4956a5e07cb34a7297ce748e9f40e899
Other Identifiers
ISSN
0366-6999
E-ISSN
2542-5641
DOI
10.1097/CM9.0000000000001216
